Cizzle Biotechnology Expands US Lab Partnership for CIZ1B Lung Cancer Test
UK diagnostics developer signs with multi-site laboratory group to scale commercial launch of early-stage lung cancer biomarker test across the United States.
Read More
Search Results for: lung cancer
Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.
Read More
Lung Cancer Screening Expands with New Guidelines, But Gaps Remain
Lung cancer screening has increased overall, but significant disparities remain, particularly among rural and underserved populations.
Read More
Lung Cancer Detection May Have Gotten Easier
Scientists have developed a low-cost, fast-response sensor capable of detecting lung cancer biomarkers from a blood sample in just 40 minutes.
Read More
Risk of Lung Cancer Recurrence Linked to ctDNA Levels
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Read More